Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor

Keyphrases

• Transplantation 100%
• Engraftment 100%
• Bone Marrow Transplantation 100%
• Fludarabine 100%
• Melphalan 100%
• Conditioning Regimen 100%
• Unrelated Donor 100%
• Allogeneic Bone Marrow Transplantation 75%
• Graft-versus-host Disease (GvHD) 50%
• HLA Matching 50%
• HLA-DRB1 50%
• HLA-DRB1 Alleles 50%
• Non-relapse Mortality 50%
• Reduced-intensity Conditioning 50%
• Donor chimerism 50%
• Number of Patients 25%
• Diarrhea 25%
• Cumulative Incidence 25%
• Cyclosporine 25%
• HLA-A 25%
• HLA-DR 25%
• Tacrolimus 25%
• Hematological Malignancies 25%
• Overall Survival Rate 25%
• Remission 25%
• Methotrexate 25%
• Graft Failure 25%
• Oral mucositis 25%
• Neutrophil Engraftment 25%
• Treatment Toxicity 25%
• HLA-mismatched Unrelated Donor 25%
• Hepatobiliary Enzymes 25%

Medicine and Dentistry

• Bone Marrow Transplantation 100%
• Engraftment 100%
• Fludarabine 100%
• Melphalan 100%
• Conditioning 100%
• Allele 75%
• Chimera 50%
• Cumulative Incidence 25%
• Survival Rate 25%
• Neutrophil 25%
• Overall Survival 25%
• Tacrolimus 25%
• Hematologic Malignancy 25%
• Cyclosporine 25%
• Diarrhea 25%
• Methotrexate 25%
• Chronic Graft Versus Host Disease 25%
• Acute Graft Versus Host Disease 25%
• HLA-A 25%
• Graft Failure 25%
• Reduced Intensity Conditioning 25%
• Oral Mucositis 25%

Immunology and Microbiology

• Engraftment 100%
• Bone Marrow Transplantation 100%
• Conditioning 100%
• Allele 75%
• Chimera 50%
• Ciclosporin 25%
• Survival Rate 25%
• HLA-DR 25%
• Neutrophil 25%
• Acute Graft Versus Host Disease 25%
• Methotrexate 25%
• Overall Survival 25%
• Tacrolimus 25%
• Chronic Graft Versus Host Disease 25%